Aktienbewertung
Konkurrenz
| Unternehmen | Börsenwert | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Novartis SWX:NOVN |
179,74 Mrd. CHF | 3,98 % | 6/6 | -1,86 % | -1,82 % | 3,44 % | DOWN |
|
AstraZeneca PLC LSE:AZN |
167,50 Mrd. £ | 15,91 % | 5/6 | -19,70 % | 9,72 % | 30,20 % | DOWN |
|
Innovent Biologics SEHK:1801 |
152,40 Mrd. HK$ | 49,13 % | 5/6 | 29,07 % | -54,27 % | 1,01 % | UP |
|
Akeso SEHK:9926 |
133,83 Mrd. HK$ | 0,00 % | 0/2 | 67,42 % | -310,23 % | -24,39 % | UP |
|
CSPC Pharmaceutical Group SEHK:1093 |
98,67 Mrd. HK$ | 5,40 % | 5/6 | 10,15 % | -12,49 % | 11,36 % | UP |
|
Shanghai Fosun Pharmaceutical (Group) SHSE:600196 |
65,25 Mrd. ¥ | 3,43 % | 4/6 | -3,07 % | 21,89 % | 8,78 % | UP |
|
Shanghai Pharmaceuticals Holding SHSE:601607 |
63,58 Mrd. ¥ | 0,25 % | 1/6 | 17,05 % | 9,65 % | 8,54 % | DOWN |
|
China Resources Sanjiu Medical & Pharmaceutical SZSE:000999 |
52,88 Mrd. ¥ | 16,86 % | 4/6 | 5,96 % | 30,70 % | 32,87 % | DOWN |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Compa... SEHK:874 |
45,51 Mrd. HK$ | 2,12 % | 3/6 | 2,24 % | 18,74 % | 18,09 % | UP |
|
Lantheus Holdings NasdaqGM:LNTH |
5,05 Mrd. $ | 31,04 % | 5/6 | -0,11 % | 30,66 % | 71,40 % | DOWN |
|
Humanwell Healthcare (Group) SHSE:600079 |
35,83 Mrd. ¥ | 5,61 % | 4/6 | 1,34 % | 16,64 % | -100,00 % | UP |
|
Livzon Pharmaceutical Group SZSE:000513 |
35,45 Mrd. ¥ | 0,00 % | 0/0 | 0,90 % | -8,79 % | 5,36 % | UP |
|
Shanghai Junshi Biosciences SEHK:1877 |
38,40 Mrd. HK$ | 14,89 % | 3/6 | 47,61 % | -3,88 % | -31,57 % | UP |
|
Telix Pharmaceuticals ASX:TLX |
7,19 Mrd. $ | 174,31 % | 3/4 | 63,51 % | 84,85 % | 60,00 % | DOWN |
|
Shanghai Henlius Biotech SEHK:2696 |
33,83 Mrd. HK$ | 115,18 % | 6/6 | 8,12 % | 24,88 % | 0,32 % | UP |
|
Zai Lab NasdaqGM:ZLAB |
4,11 Mrd. $ | 84,43 % | 2/6 | 42,37 % | 80,77 % | 50,58 % | UP |
|
Lepu Medical Technology (Beijing) SZSE:300003 |
29,03 Mrd. ¥ | -1,94 % | 0/6 | 75,85 % | -28,06 % | -11,68 % | UP |
|
China Resources Double-Crane Pharmaceutical SHSE:600062 |
20,02 Mrd. ¥ | 6,61 % | 4/6 | 2,58 % | 1,87 % | 28,27 % | UP |
|
North China Pharmaceutical Company.Ltd SHSE:600812 |
11,72 Mrd. ¥ | 0,00 % | 3/6 | 0,00 % | 0,00 % | 6,88 % | UP |
|
Harbin Pharmaceutical Group SHSE:600664 |
10,00 Mrd. ¥ | 0,00 % | 0/0 | 0,00 % | 0,00 % | 24,69 % | DOWN |
